Connect with us

DAILY BAWAL

Coronavirus India Updates: With 90,802 new cases, infections cross 42 lakh mark; metro services resume today

Published

on

metro services resume today

Coronavirus (Covid-19) India News Updates: With 90,802 new cases reported in the last 24 hours, the tally in India has now breached the 42 lakh mark. The toll stands at 71,642 with 1016 deaths reported on Sunday.

For the second day in a row, India has added more than 90,000 infections. With 90,802 new cases reported in the last 24 hours, the tally in India has now breached the 42 lakh mark. Of the 42,04,614 cases, over 32 lakh patients have been discharged, while nearly 8.9 lakh infections are still active. The toll stands at 71,642 with 1016 deaths reported on Sunday. Only the United States, where more than 61 lakh people have so far been found to be infected, is ahead of India. Haryana leader Deepender Hooda, Kerala Finance Minister Thomas Isaac are among the politicians who tested positive on Sunday.

After five months of suspension, metro rail services resumed in selected parts of the country. With face masks and social distancing protocols being mandatory, only asymptomatic people will be allowed to board the trains. Tokens or cash transactions are discouraged and only smart cards are allowed in many cities. Based on central guidelines, the metro authorities of Delhi, Noida, Chennai, Kochi, Bengaluru, Mumbai Line-1, Jaipur, Hyderabad, Maha Metro (Nagpur), Kolkata, Gujarat, and Uttar Pradesh have prepared their standard operating procedures. Maharashtra will not be resuming the metro operation this month.

In other news, the Russian research institute has now submitted “comprehensive data” on the safety and efficacy of Sputnik V vaccine to Indian authorities. As this “comprehensive data” is evaluated by experts in India, one option, sources said, is to have a separate Phase 3 clinical trial after necessary approvals from regulators here. In fact, according to the official Sputnik V website, run by sovereign wealth fund Russian Direct Investment Fund, Russia plans to conduct Phase 3 clinical trials in many countries, including Saudi Arabia, UAE, Brazil, and the Philippines.

Continue Reading